[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100473731":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":24,"locations":33,"responsibleParty":86,"collaborators":89,"id":94,"slug":10,"hasResults":95,"nctId":96,"briefTitle":97,"officialTitle":98,"acronym":10,"eligibilityCriteria":99,"healthyVolunteers":95,"sex":100,"minAge":101,"maxAge":10,"enrollmentInfo":102,"targetDuration":10,"studyType":105,"phases":10,"briefSummary":106,"conditions":107,"keywords":10,"overallStatus":36,"whyStopped":10,"lastUpdateSubmitDate":109,"lastUpdatePostDateStruct":110,"startDateStruct":113,"completionDateStruct":115,"leadSponsor":117,"locationsCount":118},{"fullName":5,"class":6},"Huazhong University of Science and Technology","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Group 1",null,"Lung cancer patients treated with thoracic radiotherapy",[13],"Other: Blood Samples for Biomarkers",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"Blood Samples for Biomarkers","blood sample to be taken at baseline, during radiotherapy, and after radiotherapy",[9],[20],{"name":21,"affiliation":22,"role":23},"Xianglin Yuan, PhD","Tongji Hospital","PRINCIPAL_INVESTIGATOR",[25,29],{"name":21,"role":26,"phone":27,"phoneExt":10,"email":28},"CONTACT","+8613667241722","yuanxianglin@hust.edu.cn",{"name":30,"role":26,"phone":31,"phoneExt":10,"email":32},"Lingyan Xiao, MD","+8615971474885","lingyan.xiao123@gmail.com",[34,56,67],{"facility":35,"status":36,"city":37,"state":38,"zip":39,"country":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology","RECRUITING","Wuhan","Hubei","43000","China",{"type":42,"coordinates":43},"Point",[44,45],114.26667,30.58333,{"lat":45,"lon":44},[48,52],{"name":49,"role":26,"phone":50,"phoneExt":10,"email":51},"Guang Han, PhD","+8613886048178","hg7913@hotmail.com",{"name":53,"role":26,"phone":54,"phoneExt":10,"email":55},"Ying Li, MD","+8613628635363","hbwhw08@163.com",{"facility":57,"status":36,"city":37,"state":38,"zip":58,"country":40,"cosmosGeoPoint":59,"geoPoint":61,"contacts":62},"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology","430030",{"type":42,"coordinates":60},[44,45],{"lat":45,"lon":44},[63,64,65],{"name":21,"role":26,"phone":27,"phoneExt":10,"email":28},{"name":30,"role":26,"phone":31,"phoneExt":10,"email":32},{"name":66,"role":23,"phone":10,"phoneExt":10,"email":10},"Xianglin Xianglin, PhD",{"facility":68,"status":36,"city":69,"state":70,"zip":71,"country":40,"cosmosGeoPoint":72,"geoPoint":76,"contacts":77},"Jingjiang People' Hospital","Jingjiang","Jiangsu","214500",{"type":42,"coordinates":73},[74,75],120.2625,32.01417,{"lat":75,"lon":74},[78,82],{"name":79,"role":26,"phone":80,"phoneExt":10,"email":81},"Dewen Wang, Bachelor","+8613815985599","jsjjwdw@163.com",{"name":83,"role":26,"phone":84,"phoneExt":10,"email":85},"Lihua Fan, MD","+8613852619599","980692748@qq.com",{"type":23,"investigatorFullName":87,"investigatorTitle":88,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Xianglin Yuan","Professor, Chief Physician",[90,92],{"name":91,"class":6},"Hubei Cancer Hospital",{"name":68,"class":93},"UNKNOWN","100473731",false,"NCT05448703","A Study on Predictive Models and Clinical Outcome of Radiation Pneumonitis","A Multicenter Prospective Observational Study on Predictive Models and Clinical Outcome of Radiation Pneumonitis","Inclusion Criteria:\n\n1. Clinical diagnosis of lung cancer by histology\n2. Radiation dose at least 45 Gy\n3. Karnofsky \\>60\n4. Age\\>18\n5. Life expectancy of at least 6 months\n\nExclusion Criteria:\n\n1. Previous thoracic irradiation\n2. Severe cardiopulmonary diseases","ALL","18 Years",{"count":103,"type":104},300,"ESTIMATED","OBSERVATIONAL","Radiation pneumonitis is the main dose-limiting toxicity of thoracic radiotherapy, which can affect life quality, survival, and the tumor-controlling effects of patients receiving thoracic radiotherapy.\n\nThe purpose of this study is to:\n\n* Identify biomarkers including serum proteins, gene expression, genetic changes, and epigenetic modifications that determine radiation pneumonitis.\n* Investigate the relationship between radiation pneumonitis and other toxicities induced by radiotherapy.\n* Construct a predictive model for radiation pneumonitis.\n* Evaluate survival and treatment outcome of patients with radiation pneumonitis.",[108],"Radiation Pneumonitis","2022-10-05",{"date":111,"type":112},"2022-10-06","ACTUAL",{"date":114,"type":112},"2021-02-25",{"date":116,"type":104},"2026-09-01",{"name":5,"class":6},3]